Contineum Therapeutics, Inc. (CTNM)
13.44
-0.01
(-0.07%)
USD |
NASDAQ |
Apr 02, 16:00
13.47
+0.03
(+0.22%)
After-Hours: 20:00
Contineum Therapeutics EPS Diluted (Quarterly) : -0.4911 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Coherus Oncology, Inc. | -0.3097 |
| ALX Oncology Holdings, Inc. | -0.4209 |
| Century Therapeutics, Inc. | -0.219 |
| Climb Bio, Inc. | -0.26 |
| PepGen Inc. | -0.2666 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.16M |
| Total Expenses (Quarterly) | 15.16M |
| Enterprise Value | 247.15M |
| Earnings Yield | -16.22% |
| Normalized Earnings Yield | -16.22 |